VulnerabilityModified
CVE-2018-17538
Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection.
CRITICAL 9.8EPSS 2.46%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (2.46%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that supports any finding of any type of vulnerability
- CVSS 3.0
- 9.8 CRITICALCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 2.46% probability · 84th percentile
- CISA KEV
- Not listed
- Affected
- axon/evidence sync
- Source
- cve@mitre.org
References
- https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/Evidence_Review_Report.pdfExploit, Third Party Advisory
- https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/Evidence_Sync_Report.pdfExploit, Third Party Advisory
- https://raw.githubusercontent.com/GitHubAssessments/CVE_Assessment_05_2018/master/Evidence_Sync_Report.pdfExploit, Third Party Advisory
- https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/Evidence_Review_Report.pdfExploit, Third Party Advisory
- https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/Evidence_Sync_Report.pdfExploit, Third Party Advisory
- https://raw.githubusercontent.com/GitHubAssessments/CVE_Assessment_05_2018/master/Evidence_Sync_Report.pdfExploit, Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.